当前位置:首页 - 行情中心 - *ST生物(000504) - 财务分析 - 现金流量表

*ST生物

(000504)

  

流通市值:31.23亿  总市值:31.32亿
流通股本:3.29亿   总股本:3.30亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金107,916,577.56277,578,602.2129,067,161.4678,890,097.05
  收到的税费返还2,294,539.583,190,5101,154,692.19316,457.29
  收到其他与经营活动有关的现金24,821,058.3919,303,835.217,412,630.734,701,244.19
  经营活动现金流入小计135,032,175.53300,072,947.41137,634,484.3883,907,798.53
  购买商品、接受劳务支付的现金179,775,628.05313,648,673.7732,055,958.3515,324,423.59
  支付给职工以及为职工支付的现金11,633,148.7358,498,525.6545,541,330.0435,670,965.23
  支付的各项税费20,592,525.9423,669,544.1111,243,358.519,596,529.29
  支付其他与经营活动有关的现金13,732,689.3319,991,551.3931,468,952.5426,276,381.4
  经营活动现金流出小计225,733,992.05415,808,294.92120,309,599.4486,868,299.51
  经营活动产生的现金流量净额-90,701,816.52-115,735,347.5117,324,884.94-2,960,500.98
二、投资活动产生的现金流量:
  收回投资收到的现金336,000,000278,000,000105,000,00040,229,390.4
  取得投资收益收到的现金577,580.394,080,006.715,328,704.213,191,627.44
  处置固定资产、无形资产和其他长期资产收回的现金净额-17,50017,50017,500
  投资活动现金流入小计336,577,580.39282,097,506.71110,346,204.2143,438,517.84
  购建固定资产、无形资产和其他长期资产支付的现金2,792,5585,119,160.3813,823.2570,200.1
  投资支付的现金456,000,000178,000,000105,000,000105,000,000
  取得子公司及其他营业单位支付的现金-61,231,129.8961,225,585.03-
  支付其他与投资活动有关的现金-10,861,942.68--
  投资活动现金流出小计458,792,558255,212,232.87167,039,408.23105,570,200.1
  投资活动产生的现金流量净额-122,214,977.6126,885,273.84-56,693,204.02-62,131,682.26
三、筹资活动产生的现金流量:
  吸收投资收到的现金-1,250,0001,250,000-
  其中:子公司吸收少数股东投资收到的现金-1,250,000--
  取得借款收到的现金-22,300,000--
  收到其他与筹资活动有关的现金56,123,571.2246,711,744.13--
  筹资活动现金流入平衡项目000-
  筹资活动现金流入小计56,123,571.2270,261,744.131,250,000-
  偿还债务支付的现金5,000,00033,515,0001,000,000500,000
  分配股利、利润或偿付利息支付的现金979,946.973,927,652.332,034,725.32393,322.53
  其中:子公司支付给少数股东的股利、利润-1,562,500--
  支付其他与筹资活动有关的现金617,4424,537,078.653,559,542.441,398,259.5
  筹资活动现金流出小计6,597,388.9741,979,730.986,594,267.762,291,582.03
  筹资活动产生的现金流量净额49,526,182.23228,282,013.15-5,344,267.76-2,291,582.03
四、汇率变动对现金及现金等价物的影响--61.29-11.45-11.45
五、现金及现金等价物净增加额-163,390,611.9139,431,878.19-44,712,598.29-67,383,776.72
  加:期初现金及现金等价物余额346,765,025.12207,333,146.93207,333,146.93207,333,146.93
  期末现金及现金等价物余额183,374,413.22346,765,025.12162,620,548.64139,949,370.21
补充资料:
  净利润-18,052,280.09--14,062,869.87
  资产减值准备-16,824,469.79-4,167,695.97
  固定资产和投资性房地产折旧-4,146,729.48-1,241,171.78
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-4,146,729.48-1,241,171.78
  无形资产摊销-438,547.29-107,459.48
  长期待摊费用摊销-23,942,583.96-5,068,149.28
  处置固定资产、无形资产和其他长期资产的损失--4,854.13--32,482.62
  固定资产报废损失-22,914.29--
  公允价值变动损失-165,128-145,895
  财务费用-2,587,541.91--217,576.42
  投资损失--7,874,289.7--3,416,948.57
  递延所得税--910,675.92--798,625.97
  其中:递延所得税资产减少--1,020,953.25--734,523.31
    递延所得税负债增加-110,277.33--64,102.66
  存货的减少-2,580,818.51-15,867,341.5
  经营性应收项目的减少--173,673,633.53--65,335,672.95
  经营性应付项目的增加--4,859,296.74-52,604,665.94
  现金的期末余额-346,765,025.12-139,949,370.21
  减:现金的期初余额-207,333,146.93-207,333,146.93
  现金及现金等价物的净增加额-139,431,878.19--67,383,776.72
公告日期2026-04-292026-04-292025-10-272025-08-28
审计意见(境内)标准无保留意见
TOP↑